肝的

At the same time, the quantity of the reperfusion liquid should be controlled; 10 ml reperfusion liquid can effectively lustrate the blood and the air that resided in the liver.Key words liver transplantation; rats; reperfusion; animal model 建立稳定大鼠原位肝移植rat orthotopic livertransplantation,ROLT

通过改进技术改善肝功能，提高了生存率，尤其在冷保存时经门静脉再灌注，在供肝的质量上明显优于不进行灌注组，并应严格掌握灌注液体量，10 ml灌注量明显优于其他液体量，能有效地驱除供肝内残留的血液和气泡。

We established heterotopic partial liver transplantation models in pigs which transplanted at right subhepatic space, two livers blood flow was limited by partially constraining host portal vein and to investigate the change of ODER when the Liver was atrophic caused by insufficient portal blood flow.

建立猪右肝下部分肝移植模型，动脉血供相同，部分缩窄宿主门静脉控制两肝门静脉血流，观察入肝血流量对移植肝或宿主肝的影响，检测血清中自由基的变化。

It was suggested that the pharmacodynamics and therapeutic function of Qizhi complex prescription to fatty liver were: 1. Adjust lipometabolism: reducing TC and TG; 2. Decreasing fatty degeneration of liver cell; 3. Promoting the convalescence of hepatocellular function; 4. Anti-lipid peroxide: increasing the activation of peroxidase, decreasing the content of products of lipid peroxide. 5. Restraining Kupffer cell function of fatty liver rat; 6. Improving fluidity of hepatocellular microsome and mitochondria.

芪枳合剂治疗脂肪肝的效应及药效学机制为： 1、调整脂质代谢：降低血清甘油三脂和胆固醇； 2、减轻肝细胞脂肪变性； 3、促进肝细胞功能恢复，有效治疗脂肪性肝炎； 4、抗脂质过氧化：提高抗氧化酶活性、降低脂质过氧化产物含量； 5、抑制脂肪肝大鼠Kupffer细胞功能； 6、改善肝细胞微粒体、线粒体膜流动性。

Results compared with model control group,dongbao gantai group, the level of body weight,liver index, tc ,tg, alt,ast in serum in tiaozhi hugan decoction group were lower significantly .the level of hld-c was higher.,the level of mda in tiaozhi hugan decoction was lower significantly, the level of sod was higher significantly（in all group p＜0.01）conclusion it suggests that the pharmacodynamics mechanisms of tiaozhi hugan decoction to fatty liver induced by high fatty diet are lowering body weight and liver index, adjusting lipometabolism, improving liver function and having anti-lipid peroxidation effects.

结果 与病理模型组、东宝甘泰组比较调脂护肝方组大鼠体重、肝指数血清tc值、tg值均降低，hld-c值增高，血清alt、ast、mda值均较低，sod值较高（各组比较p.01）。结论调脂护肝方干预非酒精性脂肪肝的药效机制为：降低体重与肝指数，调整脂质代谢，改善肝功能，抗脂质过氧化。

The pharmacodynamics and therapeutic function of Ganzhixiao decocting prescription to fatty liver as the following:1. Adjust lipometabolism:reducing TC and TG;Decreasing fatty degeneration of liver cell;2. promoting the convalescence of hepatocellular function;3. Anti-lipid peroxide:increasing the the activation of peroxidase, decreasing the content of productsof lipid peroxide.

肝脂消颗粒剂治疗脂肪肝的效应及药效学机制为： 1、调整脂质代谢：使肝酶活性增强，降低血清甘油三脂和胆固醇； 2、减轻肝细胞脂肪变牲； 3、促进肝细胞功能恢复，有效治疗脂肪性肝炎； 4、抗脂质过氧化：提高抗氧化酶活性、降低脂质过氧化产物含量。

The operational pathway by cutting down the perihepatic ligament next to the superior border of liver is a quick way with little bleeding, no hurting for diaphragm and hepatic vein, and the secundum porta hepatic can be showed clearly.

观察肝静脉的汇入情况。2结果肝的第二肝门是指肝顶部下腔静脉窝上端，有肝左、中、右静脉和一些附加的肝小静脉注入下腔静脉近端处。

This experimental study, based on the ischemia-reperfusion injury model of the isolated rabbit liver, was to investigate hepatocellular apoptosis and its mechanism during cold preservation-reperfusion of donor liver and assess the structural and functional damages of the reperfusing donor liver subsequent to rewarm ischemia. In addition, the expression and effects of ICAM-1 mRNA were mainly observed during rewarm ischemia-reperfusion of donor livers. Our experiment included three parts: The first was establishment of the isolated liver ischemia-reperfusion injury model in rabbits.

本实验在建立离体供肝缺血-再灌注损伤模型的基础上，研究供肝低温保存-再灌注过程中肝细胞凋亡现象及其相关机制；探讨作为临床肝移植中供肝的另一缺血阶段—复温缺血对再灌注后供肝结构及功能的损伤作用，并着重观察供肝复温缺血-再灌注期间组织细胞内细胞间粘附分子-1 mRNA的表达规律及其作用。

For the later 14 cases,five complications occurred,including acute reject reaction(1 case),hepatic artery thrombosis(1 case),bile leakage(1 case),left subphrenic abscess(1 case),and pulmonary infection(1 case).The patient with pulmonary infection died of MODS.14 patients underwent direct anastomosis of right hepatic vein and IVC.Among them,5 cases underwent the reconstructions of right inferior hepatic vein,and 5 received the reconstruction of the tributaries of the middle hepatic vein by interpositing a vein graft to provide sufficient venous outflow.

后14例受者中发生并发症5例：急性排斥反应，肝动脉栓塞，胆漏，左膈下脓肿及肺部感染各1例；1例再移植术后肺部感染死于MODS.14例中除肝右静脉与下腔静脉直接吻合外，其中5例加行右肝下静脉重建，另5例采用自体大隐静脉搭桥行肝中静脉分支与IVC重建，保证了右肝的流出道通畅。

For the later 14 cases, five compli- cations occurred, including acute reject reaction （1 case）, hepatic artery thrombosis （1 case）, bile leakage （1 case）,left subphrenic abscess （1 case）, and pulmonary infection （1 case）. The patient with pulmonary infection died of MODS. 14 patients underwent direct anastomosis of right hepatic vein and IVC. Among them, 5 cases underwent the reconstructions of right inferior hepatic vein, and 5 received the reconstruction of the tributaries of the middle hepatic vein by interpositing a vein graft to provide sufficient venous outflow.

后14例受者中发生并发症5例：急性排斥反应，肝动脉栓塞，胆漏，左膈下脓肿及肺部感染各1例；1例再移植术后肺部感染死于MODS.14例中除肝右静脉与下腔静脉直接吻合外，其中5例加行右肝下静脉重建，另5例采用自体大隐静脉搭桥行肝中静脉分支与IVC重建，保证了右肝的流出道通畅。

BE careful during manicuring the HA to avoid impairing it. It may evidently diminish the incidence of the complications of HA by using MVT. It is effective and safe to use coagulant factors and hemostasis drugs appropriately. It may not increase the incidence of therombosis in the HA.

原位肝移植中供肝的肝动脉变异较多见，修剪肝动脉时应加以注意，避免误伤；正确采用血管外科显微技术，可明显减少肝动脉并发症的发生；适当应用凝血因子、止血药物安全有效，不增加肝动脉血栓形成等并发症。

In the United States, chronic alcoholism and hepatitis C are the most common ones.

在美国，慢性酒精中毒，肝炎是最常见的。

If you have any questions, you can contact me anytime.

如果有任何问题，你可以随时联系我。